RESMED INC — Director's Dealing 2025

Jul 3, 2025

SEC Form 4 FORM 4

OMB APPROVAL

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB Number: 3235-0287 Estimated average burden hours per response: 0.5

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the X purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person[*]

2. Issuer Name and Ticker or Trading Symbol

3. Relationship of Reporting Person(s) to Issuer (Check all applicable)

RESMED INC [ RMD ]

FARRELL PETER C

X Director 10% Owner Officer (give title Other (specify below) below)

X contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.	X contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person* FARRELL PETER C		2. Issuer NameandTicker or Trading Symbol RESMED INC [ RMD]							5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title Other (specify
(Last) (First) (Middle) 9001 SPECTRUM CENTER BLVD. (Street) SAN DIEGO CA 92123 (City) (State) (Zip)		3. Date of Earliest Transaction (Month/Day/Year) 07/02/2025 4. If Amendment, Date of Original Filed (Month/Day/Year)							below) below)
									6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)		2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)				5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	Amount	(A) or (D)	Price
ResMed Common Stock	07/02/2025			S (1)		945	D	$ 255.49		68,273	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

1. Title of 2. 3. Transaction 3A. Deemed 4. 5. Number of 6. Date Exercisable and 7. Title and Amount of 8. Price of 9. Number of 10. 11. Nature Derivative Conversion Date Execution Date, Transaction Derivative Expiration Date Securities Underlying Derivative derivative Ownership of Indirect Security (Instr. 3) or Exercise (Month/Day/Year) if any Code (Instr. Securities (Month/Day/Year) Derivative Security (Instr. Security Securities Form: Beneficial Price of (Month/Day/Year) 8) Acquired (A) 3 and 4) (Instr. 5) Beneficially Direct (D) Ownership Derivative or Disposed of Owned or Indirect (Instr. 4) Security (D) (Instr. 3, 4 Following (I) (Instr. 4) and 5) Reported Transaction(s) Amount or (Instr. 4) Date Expiration Number of Code V (A) (D) Exercisable Date Title Shares

Explanation of Responses:

1. The transaction was conducted under a Rule 10b5-1 plan adopted May 28, 2024

Peter C. Farrell, Chairman emeritus

• ** Signature of Reporting Person

07/02/2025

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

• ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.